Alembic Pharma Financials
NSE: APLLTD | BSE: 533573
₹1,010.00
₹44.85
(4.65%)
As on 08-Nov-2026IST
Market cap
₹19,823 Cr
Revenue (TTM)
₹8,477 Cr
P/E Ratio
23.5
P/B Ratio
3.3
Div. Yield
1.2 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
8,477.28
|
7,344.90
|
6,672.08
|
6,228.63
|
5,652.62
|
5,305.78
|
|
|
|
|
|
|
Total Income
|
8,548.32
|
7,399.78
|
6,719.95
|
6,257.67
|
5,655.66
|
5,356.27
|
|
|
|
|
|
|
Total Expenditure
|
7,060.73
|
6,226.90
|
5,669.16
|
5,296.00
|
4,944.56
|
4,431.64
|
|
|
|
|
|
|
EBITDA
|
1,416.55
|
1,118.00
|
1,002.92
|
932.63
|
708.06
|
874.14
|
|
|
|
|
|
|
Depreciation
|
367.22
|
318.55
|
278.58
|
272.67
|
275.43
|
286.78
|
|
|
|
|
|
|
EBIT
|
1,049.33
|
799.45
|
724.34
|
659.96
|
432.63
|
587.36
|
|
|
|
|
|
|
Interest
|
111.74
|
93.63
|
78.77
|
56.19
|
50.17
|
17.73
|
|
|
|
|
|
|
Other Income
|
71.04
|
54.88
|
47.87
|
29.04
|
3.04
|
50.49
|
|
|
|
|
|
|
Exceptional Items
|
-66.99
|
-66.99
|
12.87
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
941.64
|
693.95
|
707.18
|
631.83
|
354.59
|
625.40
|
|
|
|
|
|
|
Provision for Tax
|
100.18
|
23.12
|
125.17
|
16.01
|
12.60
|
104.46
|
|
|
|
|
|
|
Profit after Tax
|
841.46
|
670.83
|
582.01
|
615.82
|
341.99
|
520.94
|
|
|
|
|
|
|
Minority Interest
|
4.16
|
3.94
|
1.41
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
-1.71
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
843.91
|
674.77
|
583.42
|
615.82
|
341.99
|
520.94
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
5,944.47
|
5,674.81
|
5,190.94
|
4,818.20
|
4,370.47
|
5,237.54
|
|
|
|
|
|
|
Minority Interest
|
4.16
|
-5.83
|
-1.42
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
495.52
|
230.16
|
5.05
|
2.75
|
52.42
|
162.07
|
|
|
|
|
|
|
Current Liabilities
|
3,098.56
|
2,686.87
|
2,514.27
|
1,520.28
|
1,640.80
|
1,830.59
|
|
|
|
|
|
|
Total Liabilities
|
9,530.68
|
8,855.62
|
7,874.87
|
6,510.87
|
6,186.70
|
7,236.09
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
4,249.47
|
3,920.38
|
3,519.12
|
3,197.39
|
3,149.80
|
4,255.37
|
|
|
|
|
|
|
Current Assets
|
5,222.63
|
4,635.63
|
4,189.72
|
3,143.84
|
2,913.89
|
2,974.83
|
|
|
|
|
|
|
Total Assets
|
9,530.68
|
8,855.62
|
7,874.87
|
6,510.87
|
6,186.70
|
7,236.09
|
|
|
|
|
|
|
Total Debt*
|
--
|
1,360.85
|
1,195.57
|
430.45
|
635.87
|
629.99
|
|
|
|
|
|
|
Net Current Assets
|
2,124.07
|
1,948.76
|
1,675.45
|
1,623.56
|
1,273.09
|
1,144.24
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
160.39
|
68.89
|
54.61
|
109.23
|
62.87
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
782.73
|
87.97
|
803.20
|
723.94
|
552.35
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-506.06
|
-568.41
|
-320.61
|
-447.59
|
-371.97
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-163.78
|
443.71
|
-437.86
|
-261.96
|
-217.35
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
112.89
|
-36.73
|
44.73
|
14.39
|
-36.97
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
46.86
|
34.33
|
29.68
|
31.33
|
17.40
|
26.50
|
|
|
|
|
|
|
Cash EPS (₹)
|
42.93
|
50.34
|
43.78
|
45.20
|
31.41
|
41.09
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
302.42
|
288.72
|
264.10
|
245.14
|
222.36
|
266.47
|
|
|
|
|
|
|
Dividend per Share (₹)
|
1.19
|
12.00
|
11.00
|
11.00
|
8.00
|
10.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
39.82
|
4.48
|
40.86
|
36.83
|
28.10
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
12.09
|
-31.77
|
23.68
|
5.92
|
0.75
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
11.74
|
13.51
|
13.42
|
7.44
|
11.25
|
|
|
|
|
|
|
ROE (%)
|
15.85
|
12.35
|
11.63
|
13.40
|
7.12
|
10.11
|
|
|
|
|
|
|
ROA (%)
|
9.39
|
8.23
|
8.28
|
9.93
|
5.15
|
7.34
|
|
|
|
|
|
|
EBIT Margin (%)
|
12.38
|
10.88
|
10.86
|
10.60
|
7.65
|
11.07
|
|
|
|
|
|
|
Net Margin (%)
|
9.84
|
9.07
|
8.66
|
9.84
|
6.05
|
9.73
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
6.94
|
6.42
|
6.61
|
10.92
|
15.22
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
19.68
|
10.08
|
7.12
|
10.19
|
6.54
|
-1.62
|
|
|
|
|
|
|
EBIT Growth (%)
|
24.88
|
10.37
|
9.76
|
52.55
|
-26.34
|
-54.70
|
|
|
|
|
|
|
Net Profit Growth (%)
|
45.18
|
15.26
|
-5.49
|
80.07
|
-34.35
|
-53.27
|
|
|
|
|
|
|
EPS Growth (%)
|
33.02
|
15.66
|
-5.26
|
80.07
|
-34.35
|
-54.56
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
9.32
|
7.74
|
10.24
|
-16.55
|
3.37
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
23.49
|
19.28
|
31.31
|
31.35
|
28.50
|
27.97
|
|
|
|
|
|
|
Price / Book Value
|
3.33
|
2.29
|
3.52
|
4.01
|
2.23
|
2.78
|
|
|
|
|
|
|
Dividend Yield (%)
|
1.19
|
1.81
|
1.18
|
1.12
|
1.61
|
1.35
|
|
|
|
|
|
|
EV/EBITDA
|
14.15
|
12.08
|
18.43
|
20.39
|
14.49
|
16.37
|
|
|
|
|
|
|
Close Price (₹)
|
825.45
|
663.25
|
929.75
|
984.80
|
496.35
|
741.60
|
|
|
|
|
|
|
High Price (₹)
|
998.00
|
1,107.90
|
1,303.90
|
1,094.00
|
792.90
|
1,090.00
|
|
|
|
|
|
|
Low Price (₹)
|
635.30
|
635.30
|
725.20
|
462.30
|
462.30
|
672.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
19,823.39
|
13,008.55
|
18,264.15
|
19,308.13
|
9,747.94
|
14,571.23
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.02
|
0.24
|
0.23
|
0.09
|
0.15
|
0.12
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.21
|
0.23
|
0.09
|
0.15
|
0.08
|
|
|
|
|
|
|
Current Ratio
|
1.69
|
1.73
|
1.67
|
2.07
|
1.78
|
1.63
|
|
|
|
|
|
|
Quick Ratio
|
0.83
|
0.79
|
0.76
|
0.99
|
0.88
|
0.75
|
|
|
|
|
|
|
Interest Coverage
|
9.43
|
8.41
|
9.98
|
12.24
|
8.07
|
36.27
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
22.37
|
19.96
|
20.98
|
16.45
|
18.51
|
15.21
|
|
|
|
|
|
|
Asset Turnover
|
0.95
|
1.75
|
1.91
|
2.17
|
0.85
|
0.75
|
|
|
|
|
|
|
Receivable days
|
--
|
36.70
|
32.99
|
28.10
|
59.84
|
39.75
|
|
|
|
|
|
|
Inventory Days
|
--
|
61.45
|
53.50
|
42.32
|
99.60
|
106.49
|
|
|
|
|
|
|
Payable days
|
--
|
157.72
|
164.40
|
150.62
|
148.04
|
173.51
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-59.57
|
-77.92
|
-80.19
|
11.40
|
-27.27
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
